Impact of intermittent fasting on anthropometric and clinical outcomes in non-alcoholic fatty liver disease: systematic review and meta-analysis

被引：0
|
作者：
Lange, Marcia [1 ]
Nadkarni, Devika [1 ]
Martin, Lily [1 ]
Newberry, Carolyn [2 ]
Kumar, Sonal [2 ]
Kushner, Tatyana [3 ]
机构：
[1] Icahn Sch Med Mt Sinai, New York, NY USA
[2] Weill Cornell Med, Div Gastroenterol & Hepatol, New York, NY USA
[3] Icahn Sch Med Mt Sinai, Div Liver Med, New York, NY USA
来源：
JOURNAL OF HEPATOLOGY | 2022年 / 77卷
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
THU096
引用
收藏
页码：S168 / S168
页数：1
相关论文
共 50 条
  • [31] Effects of saroglitazar in the treatment of non-alcoholic fatty liver disease or non-alcoholic steatohepatitis: A systematic review and meta-analysis
    Bandyopadhyay, Sanjay
    Samajdar, Shambo Samrat
    Das, Saibal
    [J]. CLINICS AND RESEARCH IN HEPATOLOGY AND GASTROENTEROLOGY, 2023, 47 (07)
  • [32] ASSOCIATION BETWEEN NON-ALCOHOLIC FATTY LIVER DISEASE AND CORONARY ARTERY DISEASE OUTCOMES: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Abosheaishaa, Hazem
    Mohamed, Islam
    Ghallab, Muhammad
    Alzamzamy, Ahmed
    Balassiano, Natalie
    Khan, Jawad
    Soliman, Moataz Yousry
    Elshair, Moaz
    Hussein, Mai
    Ahammed, Md Ripon
    Baig, Muhammad Almas
    Ali, Amr
    Abdelwahed, Mohammed
    Omran, Ahmed
    Nassar, Mahmoud
    [J]. HEPATOLOGY, 2023, 78 : S921 - S922
  • [33] Association between non-alcoholic fatty liver disease and coronary artery disease outcomes: A systematic review and meta-analysis
    Abosheaishaa, Hazem
    Hussein, Mai
    Ghallab, Muhammad
    Abdelhamid, Magdy
    Balassiano, Natalie
    Ahammed, Md Ripon
    Baig, Muhammad Almas
    Khan, Jawad
    Elshair, Moaz
    Soliman, Moataz Yousry
    Abdelwahed, Mohammed
    Ali, Amr
    Alzamzamy, Ahmed
    Nassar, Mahmoud
    [J]. DIABETES & METABOLIC SYNDROME-CLINICAL RESEARCH & REVIEWS, 2024, 18 (01)
  • [34] Impact of exercise training on the sarcopenia criteria in non-alcoholic fatty liver disease: a systematic review and meta-analysis
    Gonzalez, Andrea
    Valero-Breton, Mayalen
    Huerta-Salgado, Camila
    Achiardi, Oscar
    Simon, Felipe
    Cabello-Verrugio, Claudio
    [J]. EUROPEAN JOURNAL OF TRANSLATIONAL MYOLOGY, 2021, 31 (01)
  • [35] Preclinical and clinical evidence for the treatment of non-alcoholic fatty liver disease with soybean: A systematic review and meta-analysis
    Li, Yubing
    Deng, Xinyu
    Guo, Xiaochuan
    Zhang, Fangling
    Wu, Hefei
    Qin, Xuhua
    Ma, Xiao
    [J]. FRONTIERS IN PHARMACOLOGY, 2023, 14
  • [36] The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
    Nie, Qilong
    Li, Mingyang
    Huang, Caiyang
    Yuan, Yongwei
    Liang, Qiuyan
    Ma, Xiaojun
    Qiu, Tengyu
    Li, Jianhong
    [J]. JOURNAL OF TRANSLATIONAL MEDICINE, 2024, 22 (01)
  • [37] The clinical efficacy and safety of berberine in the treatment of non-alcoholic fatty liver disease: a meta-analysis and systematic review
    Qilong Nie
    Mingyang Li
    Caiyang Huang
    Yongwei Yuan
    Qiuyan Liang
    Xiaojun Ma
    Tengyu Qiu
    Jianhong Li
    [J]. Journal of Translational Medicine, 22
  • [38] Food groups and the likelihood of non-alcoholic fatty liver disease: a systematic review and meta-analysis
    He, Kaiyin
    Li, Yuting
    Guo, Xin
    Zhong, Lu
    Tang, Shaohui
    [J]. BRITISH JOURNAL OF NUTRITION, 2020, 124 (01) : 1 - 13
  • [39] Non-alcoholic fatty liver disease prevalence in Latin America: A systematic review and meta-analysis
    Rojas, Yesmi A. Ortega
    Cuellar, Claudia L. Vidal
    Barron, Karina M. Aparicio
    Arab, Juan Pablo
    Miranda, Adelina Lozano
    [J]. ANNALS OF HEPATOLOGY, 2022, 27 (06)
  • [40] Risk of non-alcoholic fatty liver disease in patients with psoriasis: a systematic review and meta-analysis
    Candia, R.
    Ruiz, A.
    Torres-Robles, R.
    Chavez-Tapia, N.
    Mendez-Sanchez, N.
    Arrese, M.
    [J]. JOURNAL OF THE EUROPEAN ACADEMY OF DERMATOLOGY AND VENEREOLOGY, 2015, 29 (04) : 656 - 662
12345